Questions

454. Deputy Rose Conway-Walsh asked the Minister for Health the reason additional payroll approval requirements are preventing newly qualified nurses from commencing employment within the HSE; the steps that are being taken to expedite these approvals; the anticipated timeframe for resolving these delays; the total number of nursing appointments currently impacted, nationally and at MUH specifically; and the supports…

1042. Deputy Rose Conway-Walsh asked the Minister for Health the reason changes to the processing, clinical review or eligibility requirements for lipoedema applications under the Cross Border Healthcare Directive were not communicated to patients in advance, having regard to the written commitment issued by the National Director of HSE National Services and Schemes on 29 August 2025 that advance notice and published…

1047. Deputy Rose Conway-Walsh asked the Minister for Health whether applications for reimbursement for lipoedema treatment under the Cross Border Healthcare Directive have been placed on hold, delayed or otherwise prevented from progressing pending clinical review or clinical advice; if so, the date on which this commenced; the reason for the decision; the number of applications affected; and the anticipated timefra…

1048. Deputy Rose Conway-Walsh asked the Minister for Health whether there has been any change since 29 August 2025 to the assessment, processing or reimbursement of applications relating to the treatment of lipoedema under the Cross Border Healthcare Directive; whether standard applications for treatment of the limbs under the Z01B code are now routinely being referred for clinical review; the date on which any such…

1051. Deputy Rose Conway-Walsh asked the Minister for Health whether applications for reimbursement under the Cross Border Healthcare Directive are processed strictly in chronological order according to their date of receipt; if not, the circumstances in which applications may be processed out of sequence; and to explain how applications for other procedures submitted in 2026 have been processed and reimbursed while …

1054. Deputy Rose Conway-Walsh asked the Minister for Health the number of applications for reimbursement relating to lipoedema treatment under the Cross Border Healthcare Directive that are currently outstanding, broken down by month of receipt from October 2025 to date; the number currently awaiting administrative processing, clinical review or clinical advice respectively; the number processed and reimbursed durin…

101. Deputy Rose Conway-Walsh asked the Minister for Health the reason for the continued delays, in some cases extending over months and years, in transitioning agency staff to permanent positions within the Health Service Executive. [72919/26]

128. Deputy Rose Conway-Walsh asked the Minister for Health the total number of scheduled operations and medical procedures cancelled at short notice across public hospitals to date in 2026; and the efforts being made to prevent such action. [72927/26]

407. Deputy Rose Conway-Walsh asked the Minister for Health if there are publicly funded health facilities in the State currently equipped, staffed and trained to provide inpatient trauma-stabilisation and specialist treatment for severe dissociative identity disorder; if not, the way in which the HSE clinically justifies the repatriation of a patient with this diagnosis from a healthcare facility outside the State p…

408. Deputy Rose Conway-Walsh asked the Minister for Health the clinical governance framework under which a local area management team is permitted to override and dismiss a formal specialist diagnosis of dissociative identity disorder (DID) made by an independent expert commissioned and funded by the HSE; the basis on which a diagnosis of DID can be dismissed when the State acknowledges it lacks the specialist exper…

409. Deputy Rose Conway-Walsh asked the Minister for Health the procedure for when cross-border therapy funded by the HSE due to lack of expertise in this State is terminated before completion and a patient is repatriated; the way in which the HSE can then provide the care for this repatriated patient when the expertise does not exist here to treat the diagnosis; and if she will make a statement on the matter. [54022…

844. Deputy Rose Conway-Walsh asked the Minister for Health the specific mechanisms in place for the treatment of the complex mental health condition of dissociative identity disorder in Mayo University Hospital and in the State as a whole; and if she will make a statement on the matter. [53251/26]

845. Deputy Rose Conway-Walsh asked the Minister for Health the number of mental health patients from Ireland currently getting residential treatment for mental health and associated conditions in the UK; and if she will make a statement on the matter. [53252/26]

846. Deputy Rose Conway-Walsh asked the Minister for Health the governance in place for mental health patients who are currently getting treatment from outside the State; and if she will make a statement on the matter. [53253/26]

847. Deputy Rose Conway-Walsh asked the Minister for Health the due diligence that is carried out before treatment centres are selected for treatment of Irish patients abroad; and if she will make a statement on the matter. [53254/26]

848. Deputy Rose Conway-Walsh asked the Minister for Health the total amount paid by the HSE for patients accessing mental health residential care in the UK for the past five years; and if she will make a statement on the matter. [53255/26]

2120. Deputy Rose Conway-Walsh asked the Minister for Health if her attention has been drawn to the difficulties being experienced by Irish students studying physiotherapy abroad in sourcing clinical placements within Irish hospitals; if her attention has been further drawn to concerns that placements are being prioritised for students attending Irish universities; the steps her Department will take to support such s…

832. Deputy Rose Conway-Walsh asked the Minister for Health whether the drug sotatercept, approved for the treatment of pulmonary hypertension in other jurisdictions, will be made available to patients in Ireland; and if she will make a statement on the matter. [31813/26]

3176. Deputy Rose Conway-Walsh asked the Minister for Health the actions being taken to address the ongoing recruitment and retention crisis affecting radiography practice tutors across the State, and particularly at MUH; if there are plans to increase the number of radiography practice tutors positions in line with increasing students numbers; the steps being taken to ensure pay parity for these tutors in line with …

3367. Deputy Rose Conway-Walsh asked the Minister for Health to outline where responsibility lies for ensuring medical card holders have access to adequate GP services in their own communities; and if she will make a statement on the matter. [27092/26]

3368. Deputy Rose Conway-Walsh asked the Minister for Health to outline where responsibility lies for ensuring private patients have access to adequate GP services in their own communities; and if she will make a statement on the matter. [27093/26]

3370. Deputy Rose Conway-Walsh asked the Minister for Health the number of requests received in Mayo in 2024 and in 2025 for assistance with assignment to a GP or a dentist for medical card holders, free gp card holders, or by people without such qualification, in tabular form. [27109/26]

3371. Deputy Rose Conway-Walsh asked the Minister for Health the number of people waiting for diagnostic tests at MUH at the end of quarter 1 2026, in tabular form. [27110/26]

3372. Deputy Rose Conway-Walsh asked the Minister for Health the number of patients on primary care and community services waiting lists in Mayo, by service, age and length of wait at the end of quarter 1 2026, in tabular form. [27111/26]

3373. Deputy Rose Conway-Walsh asked the Minister for Health the current number of persons waiting for home support, and those receiving less than their allocated hours, in Mayo, in tabular form. [27112/26]